ADC Therapeutics (ADCT) Cost of Revenue (2021 - 2026)
ADC Therapeutics (ADCT) recorded Cost of Revenue of $2.35 million in Q2 2026, up 181.0% from $836,000 a year earlier but down 35.0% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Cost of Revenue (2021 - 2026) Analysis & Trends
On a TTM basis, ADC Therapeutics' Cost of Revenue came in at $8 million as of Jun 30, 2026, up 61.2% year-over-year.
- Quarterly Cost of Revenue has ranged from $208,000 in Q3 2023 to $3.62 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cost of Revenue rose in four of the last six quarters, with growth averaging 92.9%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 325.4% in Q1 2024, against a decline of 83.9% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | ADC Therapeutics | 192.88 Mn | -707.77 Mn | 19.74 Mn | 1.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.98 Mn |
| Jun 30, 2026 | 2.35 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 836,000.00 |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 851,000.00 |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 208,000.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 590,000.00 |
| Dec 31, 2022 | 489,000.00 |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 2.27 Mn |
| Mar 31, 2022 | 529,000.00 |
| Dec 31, 2021 | 770,000.00 |
API Access
ADC Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();